BioSpace News Archive

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata,” “us,” “our,” or the “Company”), today provided an update on its development programs reflecting sustained clinical progress and a strengthened financial position.

Thermo Fisher Scientific Inc., the world leader in serving science, announced that it is giving notice of its intention to redeem the following Senior Notes, representing an aggregate total principal amount of approximately $2.2 billion, on December 3, 2021.

Kintara Therapeutics, Inc. (Nasdaq: KTRA) (“Kintara” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced data from two scientific posters for its Phase 2 clinical studies of VAL-083, the Company’s lead compound for the treatment of glioblastoma multiforme (GBM).

Aspen Neuroscience, Inc., a private biotechnology company developing the first autologous neuron replacement therapies to treat Parkinson’s disease, announced that Xiaokui Zhang, Ph.D., has joined the company as Chief Scientific Officer and as a member of the company’s executive team.

Better Therapeutics, Inc today announced the completion of patient enrollment in its potentially pivotal study to evaluate the safety and efficacy of BT-001 for the treatment of type 2 diabetes.

180 Life Sciences Corp. announced that Professor Jagdeep Nanchahal from the University of Oxford, a co-founder of 180 Life Sciences, will present a keynote address entitled ‘Re-purposing anti-TNF for Dupuytren’s Disease’ at the 2021 International Dupuytren Symposium on Wednesday, December 1, 2021 at 3pm EST.

Veru Inc., an oncology biopharmaceutical company with a focus on developing novel medicines for the management of breast and prostate cancer, announced that it will report financial results for its fiscal 2021 fourth quarter and full year ended September 30, 2021, on Thursday, December 2, 2021, before the market opens.

Cara Therapeutics, Inc. today announced that Christopher Posner, President and Chief Executive Officer, Thomas Reilly, Chief Financial Officer, and Joana Goncalves, M.D., Chief Medical Officer, will participate in a fireside chat at the Piper Sandler 33rd Annual Virtual Healthcare Conference. The fireside chat will be available beginning Monday, November 22, 2021 at 10:00 a.m. ET.

EsoCap AG, the Swiss biotech company dedicated to improving the lives of patients with serious diseases of the upper gastrointestinal tract, announced that it has successfully completed a financing round raising new private funding.

GlaxoSmithKline (GSK) plc today announced 11 abstracts on Blenrep will be presented at the upcoming American Society of Hematology (ASH) Annual Meeting and Exposition, to be hosted in Atlanta, Georgia, US and virtually, December 11-14, 2021.